✦ LIBER ✦

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Scribed by A.S.T. Planting; P.H.M. de Mulder; A. de Graeff; J. Verweij

Book ID: 117663574
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 694 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00311-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of concurrent chemoradiot

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Kim, J G; Sohn, S K; Kim, D H; Baek, J H; Jeon, S B; Chae, Y S; Lee, K B; Park, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

High-dose intra-arterial cisplatin and c

High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase II study

✍ William F. Regine; Joseph Valentino; William John; Gayle Storey; David Sloan; Da 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

Induction chemotherapy with cisplatin/do

Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study

✍ Emilio Fonseca; Juan José Grau; Javier Sastre; Jesús María García-Gómez; Antonio 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase II trial: concurrent radio-chemoth

Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

✍ A. Biete Solà; J. Marruecos Querol; F. A. Calvo Manuel; E. Verger Fransoy; À. Ro 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 469 KB

9 A study of weekly low-dose cisplatin c

9 A study of weekly low-dose cisplatin concurrent with radiotherapy in squamous cell carcinoma of the head and neck

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Phase II study of mitoxantrone in advanc

Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck

✍ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap